1. Home
  2. TMP vs ABCL Comparison

TMP vs ABCL Comparison

Compare TMP & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tompkins Financial Corporation

TMP

Tompkins Financial Corporation

HOLD

Current Price

$101.03

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.34

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMP
ABCL
Founded
1836
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
TMP
ABCL
Price
$101.03
$5.34
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$87.00
$8.40
AVG Volume (30 Days)
84.5K
6.8M
Earning Date
04-24-2026
05-11-2026
Dividend Yield
3.21%
N/A
EPS Growth
126.16
10.91
EPS
1.82
N/A
Revenue
$75,742,000.00
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.94
$21.85
P/E Ratio
$50.91
N/A
Revenue Growth
N/A
160.56
52 Week Low
$61.87
$2.75
52 Week High
$97.12
$8.44

Technical Indicators

Market Signals
Indicator
TMP
ABCL
Relative Strength Index (RSI) 69.39 38.49
Support Level $81.87 $5.23
Resistance Level N/A $5.63
Average True Range (ATR) 2.16 0.54
MACD 0.15 -0.25
Stochastic Oscillator 97.41 0.32

Price Performance

Historical Comparison
TMP
ABCL

About TMP Tompkins Financial Corporation

Tompkins Financial Corp is a Financial Holding Company. The company manages its operations through two business segments, consisting of banking and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates the majority of its revenue from the Banking segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: